| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.56B | 1.53B | 1.32B | 1.00B | 764.04M | 929.98M |
| Gross Profit | 723.36M | 591.13M | 597.97M | 475.36M | 308.35M | 659.27M |
| EBITDA | 133.19M | 148.36M | 89.48M | 39.34M | -321.49M | 203.48M |
| Net Income | 61.67M | 47.58M | -34.13M | -58.54M | -297.50M | 124.86M |
Balance Sheet | ||||||
| Total Assets | 1.21B | 1.25B | 1.19B | 1.22B | 1.29B | 1.42B |
| Cash, Cash Equivalents and Short-Term Investments | 10.74M | 32.40M | 42.69M | 83.16M | 141.00M | 286.45M |
| Total Debt | 422.85M | 415.91M | 713.92M | 731.80M | 745.06M | 505.30M |
| Total Liabilities | 660.05M | 673.84M | 877.11M | 872.28M | 898.95M | 756.82M |
| Stockholders Equity | 546.93M | 575.52M | 316.80M | 346.97M | 391.11M | 667.04M |
Cash Flow | ||||||
| Free Cash Flow | -24.39M | -13.86M | 3.57M | -28.50M | -372.96M | -138.43M |
| Operating Cash Flow | -16.68M | -11.67M | 15.24M | -19.38M | -338.31M | -115.44M |
| Investing Cash Flow | -12.72M | -11.31M | -14.85M | -9.13M | -42.58M | -64.02M |
| Financing Cash Flow | 34.66M | 17.36M | -40.86M | -29.34M | 235.43M | 97.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
57 Neutral | $35.01M | 13.92 | 4.56% | ― | 19.30% | -17.56% | |
56 Neutral | $123.98M | 108.63 | 5.88% | ― | 16.79% | ― | |
50 Neutral | $246.36M | ― | 15.11% | ― | 13.16% | ― | |
43 Neutral | $6.47M | ― | -146.43% | ― | -6.84% | 97.23% | |
43 Neutral | $26.98M | -1.75 | -11.18% | ― | 624.24% | 85.46% | |
41 Neutral | $47.15M | -0.18 | -142.05% | ― | 7.56% | -344.04% |
On November 11, 2025, SelectQuote, Inc. held its 2025 Annual Meeting of Stockholders, where 114,443,928 shares were represented. During the meeting, two Class III directors were elected, Deloitte & Touche LLP was ratified as the independent accounting firm for the fiscal year ending June 30, 2026, and the compensation for the company’s named executive officers was approved.
The most recent analyst rating on (SLQT) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on SelectQuote stock, see the SLQT Stock Forecast page.
SelectQuote Inc., a company specializing in offering unbiased insurance comparisons, operates primarily in the insurance and healthcare services sectors. The company provides a range of services including Medicare Advantage plans, prescription drug delivery, and life insurance.
SelectQuote’s recent earnings call revealed a mixed sentiment, reflecting both achievements and challenges faced by the company. On the positive side, SelectQuote reported significant revenue growth in its consolidated and Life Insurance business, alongside operational successes with the new Kansas facility. However, the company encountered difficulties with declining revenues in the Senior segment due to policy changes and a substantial EBITDA impact in Healthcare Services caused by reimbursement rate adjustments. These hurdles have led to unmet fiscal targets, impacting the overall sentiment of the earnings call.
During SelectQuote Inc’s recent earnings call, the sentiment was notably positive, driven by strong revenue growth and impressive agent productivity. However, the company acknowledged challenges in the Medicare Advantage market and anticipated lower EBITDA margins in fiscal 2026. The integration of technology and AI was highlighted as a promising avenue for future efficiency gains.
SelectQuote Inc., a company specializing in providing insurance comparisons and healthcare services, operates in the insurance and healthcare sectors, offering a unique blend of insurance brokerage and healthcare solutions.